WORKSHOP: Acute pulmonary embolism to chronic thromboembolic pulmonary hypertension
(CTEPH): State of the art management
Organised in collaboration with the Pulmonary Vascular Research Institute
| 0830-0900 | Pulmonary embolism: A background | |
| 0900-0930 | Case Discussion 1: Risk stratification | |
| 0930-1000 | The role of imaging in pulmonary embolism | |
| 1000-1030 | Management of confirmed pulmonary embolism | |
| 1030-1100 | Coffee break | |
| 1100-1130 | Case Discussion 2: To thrombolyse or not to thrombolyse? | |
| 1130-1200 | Case Discussion 3: The argument for and against lifelong anticoagulation | |
| 1200-1230 | Management of bleeding in anti-coagulated patients | |
| 1230-1330 | Lunch break | |
| 1330-1400 | Case Discussion 4: CTEPH – an easily missed-diagnosis | |
| 1400-1430 | Investigating suspected CTEPH | |
| 1430-1500 | Medical intervention for CTEPH – do the drugs work? | |
| 1500-1515 | Coffee break | |
| 1515-1545 | Balloon pulmonary angioplasty | |
| 1545-1615 | The surgical approach to CTEPH | |
| 1615 | Close | |
| 1630-1730 | Meeting of Pulmonary Vascular Research Institute Regional Taskforce | |
| 1845-1935 | Sponsored Symposium 1A (SS1A) |
Sponsored Symposium 1B (SS1B) |
| 0700-0800 | Registration |
| 0800-0810 | Welcome Address by: • MTS Annual Congress 2017 Organising Chairman • MTS President |
| 0810-0850 | PLENARY 1 (P1) Plenary Title: The Future of Pulmonary Hypertension |
| 0850-1005 | SYMPOSIUM 1 (S1) S1A – Occupational and Environmental Lung Disease • The impact of environmental factors on lung defences • Climate change and lung disease • Occupational ILD S1B – Ethics & medicolegal matters • Palliative care – when, where and how? • Implementing a culture of safety • Combating pseudoscience S1C – Difficult asthma in children • Difficult asthma in children, who are they? • Severe allergy asthma • Best way to recognize and manage Brittle asthma in children |
| 1005-1035 | Coffee break |
| 1035-1150 | SYMPOSIUM 2 (S2) S2A – Tuberculosis I • Review of National Tuberculosis Control Programme • Finding the missing cases • Tuberculosis in children S2B – Pulmonary manifestations of systemic disease • Sarcoidosis • Pleural disease • Lung-dominant connective tissue disease S2C – Current childhood asthma phenotypes • Asthma phenotypes based on clinical and symptoms • Childhood asthma and genetic, what is the clinical application? • Phenotype focus management, is it practical? |
| 1150-1240 | SPONSORED SYMPOSIUM 2 (SS2) Company: AstraZeneca |
| 1240-1430 | Lunch and Friday prayers |
| 1430-1600 | SYMPOSIUM 3 (S3) S3A – Pleural Disease • Malignant pleural effusion randomised trials: AMPLE TIME or ASAP? • Empyema • VATS – when to call a surgeon S3B – Sleep-disordered breathing • Obstructive sleep apnoea and the metabolic syndrome • When to call a neurologist? • Obesity hypoventilation syndrome S3C – Primary immumedeficiency (PID) and respiratory complications • Overview of primary immune deficiency in children • Respiratory complications in primary immune deficiency • Optimal management for children with PID |
| 1600-1650 | SPONSORED SYMPOSIUM 3 (SS3A) Company: GlaxoSmithKline Pharmaceutical SPONSORED SYMPOSIUM 3 (SS3B) Company: Sanofi Pasteur |
| 1650-1845 | Coffee break and MTS Annual General Meeting |
| 1845-1935 | SPONSORED SYMPOSIUM 4 (SS4) Company: Roche |
| 1935-2200 | Dinner |
| 0700-0800 | Sunrise Session: The role of inhaled antibiotics |
| 0800-0840 | PLENARY 2 (P2) Title: Lung disease of prematurity and long term outcome |
| 0840-1010 | SYMPOSIUM 4 (S4) S4A - Asthma • Severe asthma – what to do when the inhalers don’t work • The role of biomarkers in asthma management • mHealth to improve patient management S4B - Non-invasive ventilation • The effect of transnasal insufflation • Home BiPAP in the management of COPD • Neuromuscular diseases S4C - Craniofacial deformity and impact on respiratory system • Common craniofacial syndromes and their comorbidities • Airway complications and management • Management of other co-morbidities |
| 1010-1040 | Coffee break |
| 1040-1210 | SYMPOSIUM 5 (S5) S5A - Lung cancer • Lung cancer screening • Re-biopsies in known cases of lung cancer • Immunotherapy in lung cancer S5B - Respiratory infections • MDRO in the ICU • Invasive aspergillosis • Preparing for the next flu pandemic S5C - Congenital airway and diaphragm defects in children • Congenital airway and diaphragm defects: From common to rare • Outcome and management of survivors • Respiratory complications |
| 1210-1300 | SPONSORED SYMPOSIUM 5 (SS5) Company: Boehringer Ingelheim |
| 1300-1400 | Lunch |
| 1400-1530 | Multi-disciplinary case discussions (physician/radiologist/pathologist) |
| 1520-1620 | CONCURRENT ORAL AND POSTER PRESENTATIONS |
| 1630-1720 | SPONSORED SYMPOSIUM 6A (SS6) Company: Novartis |
| 1720-1750 | Coffee break |
| 1800-1850 | SPONSORED SYMPOSIUM 7 (SS7) Company: GlaxoSmithKline Pharmaceutical |
| 2000-2200 | MTS GALA DINNER Launch of Asthma Malaysia |
| 0700-0800 | Sunrise Session: Critical care medicine for the respiratory physician |
| 0800-0840 | PLENARY 3 (P3) Title: The National Strategic Plan for Tobacco Control |
| 0840-1010 | SYMPOSIUM 6 (S6) S6A - Tuberculosis II • Drug resistant TB • Update on HIV/TB co-infection • Novel anti-tuberculous medication S6B - Interventional Respiratory Techniques • Navigational bronchoscopy • Pleural interventions • Endobronchial thermoplasty S6C - Inherited metabolic and genetic diseases in children • Inherited metabolic diseases: What the paediatrician should know • Respiratory management in inherited metabolic diseases • Congenital skeletal abnormalities and respiratory insufficiency |
| 1010-1040 | Coffee break |
| 1040-1130 | SPONSORED SYMPOSIUM 8 (SS8) Company: Mundipharma |
| 1130-1230 | Forum: The role of clinicians in patient advocacy |
| 1230-1240 | Closing Ceremony |
| 1240-1410 | Lunch |
This C​onference has been accredited for CPD points as follows:
MMC CPD Grading System
Congress workshop on 20th July 2017- 6 CPD points under Category A3
Conference from 21st to 23rd July 2017 – 20 CPD points under Category A1
Malaysian Nursing Board
Congress workshop on 20th July 2017​ - 10 CPD points under Category A1
Conference from 21st to 23rd July 2017 – 20 CPD points under Category A1
Sunway Putra Hotel - It is a renowned 5-star international hotel in Kuala Lumpur offers business & leisure travellers a homelike experience.
Address: 100 Jalan Putra, 50350 Kuala Lumpur, Malaysia
Tel: 603 4040 9888
Fax: 603 4043 0700
Website: www.putra.sunwayhotel.com
